跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
連結會在新分頁中打開
English
中文
在 臺北醫學大學 搜尋內容
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
查看斯高帕斯 (Scopus) 概要
吳 佳璋
主治醫師
,
衛生福利部雙和醫院
成員
,
臺北醫學大學泌尿腎臟研究中心
https://orcid.org/0000-0001-7476-0772
電子郵件
charleswjj
yahoo.com
tw
h-index
1143
引文
19
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
2005
2026
每年研究成果
概覽
指紋
網路
專案
(6)
研究成果
(95)
資料集
(1)
類似的個人檔案
(12)
指紋
查看啟用 Chia-Chang Wu 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Medicine and Dentistry
Transitional Cell Carcinoma
100%
Nephroureterectomy
74%
Overall Survival
32%
Bladder
29%
Cancer Specific Survival
28%
Upper Urinary Tract
28%
Inguinal Hernia
27%
Urothelial Cancer
26%
Disease Free Survival
24%
Recurrent Disease
23%
Cohort Analysis
22%
Hernioplasty
19%
Urinary System
19%
Recurrence Free Survival
17%
Chronic Kidney Disease
14%
Ureter Tumor
13%
Clear Cell Renal Cell Carcinoma
13%
Neoplasm
13%
Hydronephrosis
11%
Bladder Cancer
11%
Urinary Tract
10%
Herniorrhaphy
9%
Cardiovascular Disease
9%
Hazard Ratio
9%
Adjuvant Chemotherapy
9%
Oncology
9%
Hernia
9%
Prognostic Factor
9%
Prostate Cancer
9%
Upregulation
9%
Erectile Dysfunction
9%
Meta-Analysis
9%
Percutaneous Nephrolithotomy
9%
Carcinogenicity
9%
Stent Placement
9%
Randomized Clinical Trials
9%
Extracorporeal Shockwave Therapy
9%
Testosterone
9%
Postoperative Complication
8%
Odds Ratio
8%
Proportional Hazards Model
8%
Retrospective Study
7%
Malignant Neoplasm
7%
Multivariate Analysis
7%
Prevalence
7%
Subgroup Analysis
7%
Pelvic Tumor
7%
End Stage Renal Disease
7%
Median Follow Up
6%
Kidney Stone
6%
Biochemistry, Genetics and Molecular Biology
Genotyping
20%
Tumor Necrosis Factor
14%
Interleukin 8
13%
Testosterone
13%
Tumor Necrosis Factor Alpha
12%
Cigarette Smoking
11%
Passive Smoking
10%
Arginine
9%
Methylation
9%
Uropathogenic Escherichia Coli
9%
Gene Promoter
9%
Metabolomics
9%
Case-Control Study
7%
Interleukin 6
7%
Overall Survival
6%
Carcinogenesis
5%
Transcriptome
5%
Gleason Score
5%
Cell Migration
5%
Survival Rate
5%
Promoter Region
5%
Signal Transduction
5%
Upregulation
5%
Cell Motility
5%
Pharmacology, Toxicology and Pharmaceutical Science
Transitional Cell Carcinoma
31%
Prostate Cancer
18%
Neoplasm
14%
Recurrent Disease
14%
Renal Cell Carcinoma
13%
Bladder Cancer
10%
Diseases
10%
Uropathogenic Escherichia Coli
9%
Castration Resistant Prostate Cancer
9%
Cohort Study
9%
Testosterone
9%
Overall Survival
6%
Carcinogenesis
6%
Androgen
6%
Malignant Neoplasm
5%
Inflammation
5%
End Stage Renal Disease
5%
Enzalutamide
5%
Chronic Kidney Failure
5%
